Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors

ABSTRACT: The purpose of this first-in-human study is to evaluate the safety, tolerability, pharmacokinetics, and preliminary clinical activity of M9140 in advanced solid tumors. Study details include: * Study Duration per participant: Approximately 4 months * M9140 is not available through an expanded access program

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2742179 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR